Home > Inhaler Testing > Improving IVIVCs > IVIVC Test Systems for DDU and APSD > Nebulisers

IVIVC Test Systems for DDU and APSD

Two factors have been identified as being critical to improving the clinical relevance of DDU testing and APSD measurement: realistic breathing profiles and realistic throat and nasal models.

MDIs/DPIs/SMIs

Nebulisers

Nasal Products

MDIs/DPIs/SMIs

Nebulisers

Nasal Products

Please select an option:

Realistic DDU Realistic APSD

Learn More

Please select an option:

Realistic DDU Realistic APSD

Learn More

Related Services

Training

We offer a range of training courses, presentations and seminars covering a wide range of topics.

Find Out More

Servicing

A comprehensive range of both in-house and on-site product servicing options are available

Find Out More

Support

Our team of experienced technicians and engineers are on hand to help and advise

Find Out More

IVIVC Test Systems for DDU and APSD

Related Services

Training

Servicing

Support

Related News & Resources

Copley introduces the new Patient Exhalation Simulator to help with inhaler development to understand the impact of poor patient technique.

Copley introduces the new Flow Rate Sensor, a dedicated device for inhaler testing systems.

The new DUSA Shaker™ DTS 100i from Copley: For faster, safer, more repeatable inhaler testing

Copley launches EnviroMate™, an efficient, benchtop environmental chamber for inhaler testing

Copley Scientific joins the Industries Forum of the Taskforce for Lung Health

Copley announces a major upgrade of the world’s ‘go to’ inhaler testing portfolio

New e-Training service from Copley for pharmaceutical testing

Improving clinical realism: Upgraded IVIVC testing systems from Copley Scientific

Advancing the science of OINDPs: Copley Scientific joins IPAC-RS

New research demonstrates the ability of the Child Alberta Idealised Throat to deliver better IVIVRs

Copley Scientific introduces improved test set-up for more representative inhaled product testing

Introducing the new Alberta Idealized Throats from Copley Scientific – closer IVIVC in inhaled product testing

More precise nebuliser testing as Copley Scientific launches NGI Cooler

Bridging the Gap: Enhancing the Clinical Realism of In Vitro OINDP Testing

Understanding the Links Between Drug Delivery Route and In Vitro Test Methods

Reducing Inhaler Testing Variability Through Test Environment Control

Semi-Automating Inhaler Testing – A Good Idea, but Where to Start?

Putting Inhalers to the Test

A short Q&A with our CEO, Mark Copley, On Inhaled Product Testing

Optimizing the Role of Automation in Variability Reduction Strategies For Delivered Dose Uniformity (DDU) and Aerodynamic Particle Size Distribution (APSD) Testing of Inhaled Drug Products

The Regulatory Landscape for OINDPs – The Biggest Shake-up in A Generation?

Optimizing the Application of In Vitro Test Methods for the Demonstration of Bioequivalence in Orally Inhaled Products

Demonstrating Bioequivalence of Orally Inhaled Products

Optimising the Application of In Vitro Test Methods for the Demonstration of BE in OIPs

Register your interest: Inhaler Testing Academy

IVIVC Test Systems for DDU and APSD

Mouthpiece Adapter

Filter Holder and Adapter for BRS 200i

BRS 200i Breathing Simulator

DDU of Nebulisers

Mouthpiece Adapter

Filter Holder and Adapter for BRS 200i

BRS 200i Breathing Simulator

DDU of Nebulisers

Related Services

Training

Servicing

Support

Related News & Resources

Copley introduces the new Patient Exhalation Simulator to help with inhaler development to understand the impact of poor patient technique.

Copley introduces the new Flow Rate Sensor, a dedicated device for inhaler testing systems.

The new DUSA Shaker™ DTS 100i from Copley: For faster, safer, more repeatable inhaler testing

Copley launches EnviroMate™, an efficient, benchtop environmental chamber for inhaler testing

Copley Scientific joins the Industries Forum of the Taskforce for Lung Health

Copley announces a major upgrade of the world’s ‘go to’ inhaler testing portfolio

New e-Training service from Copley for pharmaceutical testing

Improving clinical realism: Upgraded IVIVC testing systems from Copley Scientific

Advancing the science of OINDPs: Copley Scientific joins IPAC-RS

New research demonstrates the ability of the Child Alberta Idealised Throat to deliver better IVIVRs

Copley Scientific introduces improved test set-up for more representative inhaled product testing

Introducing the new Alberta Idealized Throats from Copley Scientific – closer IVIVC in inhaled product testing

More precise nebuliser testing as Copley Scientific launches NGI Cooler

Bridging the Gap: Enhancing the Clinical Realism of In Vitro OINDP Testing

Understanding the Links Between Drug Delivery Route and In Vitro Test Methods

Reducing Inhaler Testing Variability Through Test Environment Control

Semi-Automating Inhaler Testing – A Good Idea, but Where to Start?

Putting Inhalers to the Test

A short Q&A with our CEO, Mark Copley, On Inhaled Product Testing

Optimizing the Role of Automation in Variability Reduction Strategies For Delivered Dose Uniformity (DDU) and Aerodynamic Particle Size Distribution (APSD) Testing of Inhaled Drug Products

The Regulatory Landscape for OINDPs – The Biggest Shake-up in A Generation?

Optimizing the Application of In Vitro Test Methods for the Demonstration of Bioequivalence in Orally Inhaled Products

Demonstrating Bioequivalence of Orally Inhaled Products

Optimising the Application of In Vitro Test Methods for the Demonstration of BE in OIPs